Evaluation of patients' experiences with antidepressants reported by means of a medicine reporting system.

scientific article

Evaluation of patients' experiences with antidepressants reported by means of a medicine reporting system. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00228-007-0375-4
P932PMC publication ID2071966
P698PubMed publication ID17874086
P5875ResearchGate publication ID5969050

P50authorToine EgbertsQ57121903
Mark de GrootQ60611611
Eibert R. HeerdinkQ60717637
P2093author name stringE C G van Geffen
R van Hulten
S W van der Wal
P2860cites workPostmarketing surveillance of enalapril. I: Results of prescription-event monitoringQ28359865
Patient risk profiles and practice variation in nonadherence to antidepressants, antihypertensives and oral hypoglycemics.Q33281702
Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimateQ33980401
The value of reporting therapeutic ineffectiveness as an adverse drug reactionQ34005788
Determinants of signal selection in a spontaneous reporting system for adverse drug reactionsQ34459049
Patient adherence in the treatment of depressionQ34514178
Treatment non-adherence in affective disorders.Q34592227
Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medicationQ34629048
Improving adherence to antidepressants: a systematic review of interventionsQ35631511
Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.Q36024366
Attitudinal survey of voluntary reporting of adverse drug reactionsQ36053857
The role of the primary care physician in patients' adherence to antidepressant therapy.Q40570973
Can adverse drug reactions be detected earlier? A comparison of reports by patients and professionals.Q41966060
Spontaneous lapses in dosing during chronic treatment with selective serotonin reuptake inhibitorsQ43814364
Discontinuing or switching selective serotonin-reuptake inhibitorsQ43936402
Physician alerts to increase antidepressant adherence: fax or fiction?Q50114973
High Medication Discontinuation Rates in PsychiatryQ58809502
Compliance with antidepressants in a primary care setting, 1: Beyond lack of efficacy and adverse eventsQ74617402
[Direct reporting of side effects by the patient: favourable experience in the first year]Q81555529
P433issue12
P304page(s)1193-1199
P577publication date2007-09-15
P1433published inEuropean Journal of Clinical PharmacologyQ1376707
P1476titleEvaluation of patients' experiences with antidepressants reported by means of a medicine reporting system
P478volume63

Reverse relations

cites work (P2860)
Q34792882A Pill for the Ill? Patients' Reports of Their Experience of the Medical Encounter in the Treatment of Depression
Q37588434Antidepressants in primary care: patients' experiences, perceptions, self-efficacy beliefs, and nonadherence
Q36015119Consumer Narratives in ADR Reporting: An Important Aspect of Public Health? Experiences from Reports to a Swedish Consumer Organization
Q81407191Current awareness: pharmacoepidemiology and drug safety
Q43443984Economic factors in of patients' nonadherence to antidepressant treatment
Q34519989Experiences from consumer reports on psychiatric adverse drug reactions with antidepressant medication: a qualitative study of reports to a consumer association
Q35097961Implementing guidelines for depression on antidepressant prescribing in general practice: a quasi-experimental evaluation
Q38240932Issues in online patient self-reporting of health status.
Q26752684Patient Participation and the Use of Ehealth Tools for Pharmacoviligance
Q28645804Pharmacovigilance from social media: mining adverse drug reaction mentions using sequence labeling with word embedding cluster features
Q39214070Primary-care patients' trade-off preferences with regard to antidepressants.
Q26796436Profile of vortioxetine in the treatment of major depressive disorder: an overview of the primary and secondary literature
Q50739616Reasons for and time to discontinuation of rimonabant therapy: a modified prescription-event monitoring study.
Q34677835Serotonin and Antidepressant SSRIs Inhibit Rat Neuroendocrine Dopamine Neurons: Parallel Actions in the Lactotrophic Axis.
Q38190342TIDAL WAVES: Network mechanisms in the neuroendocrine control of prolactin release
Q38648733The Role of Curcumin Administration in Patients with Major Depressive Disorder: Mini Meta-Analysis of Clinical Trials
Q34057639What can we learn from consumer reports on psychiatric adverse drug reactions with antidepressant medication? Experiences from reports to a consumer association